Ayahuasca has gained global popularity, raising concerns about cultural appropriation and ecological impacts while offering potential benefits when integrated with Western mental health practices.
Psilocybin reduces alcohol consumption in rats by altering specific brain pathways, suggesting potential for new treatments for alcohol use disorder, according to a study published in Brain.
Older adults attending psychedelic retreats reported significant well-being improvements, driven by social connections and group activities, despite experiencing less intense immediate psychedelic effects compared to younger participants.
Neuroimaging research has found that psilocybin increases self-inhibition in visual brain regions and enhances top-down connectivity, leading to vivid, internally generated visual imagery with eyes closed.
In recent years, the resurgence of interest in psychedelic substances has spotlighted psilocybin as a potential breakthrough in mental health treatment.
Psilocybin significantly reduced the frequency and severity of cluster headaches, with participants experiencing approximately a 50% decrease in weekly attacks and improvements in pain severity and medication use.
Researchers observed a 1250% increase in microdosing-related Google searches from 2015 to 2023, coinciding with the loosening of cannabis and psychedelic regulations, with over three million searches in 2023 alone.
People who use psychedelics tend to have higher levels of BDNF, a brain protein that promotes neuroplasticity and neuron growth, suggesting potential mental health benefits.
The psychedelic substance known as psilocybin initially increases then decreases neural responsiveness to sound in the mouse auditory cortex while enhancing functional connectivity.
MDMA enhances empathy-like behaviors in mice through serotonin release in the nucleus accumbens, with significant effects in males but not females, and reverses empathy deficits in a mouse model of autism spectrum disorder.
Microdosing LSD leads to participants sleeping 24 minutes longer and going to bed 25 minutes earlier, with an 8-minute increase in REM sleep, according to a recent study published in Translational Psychiatry.
Researchers found that the psychedelic 5-MeO-DMT induces brain activity patterns in rats that resemble those seen during sleep, even while they are awake. This suggests a unique state blending wakefulness and sleep-like brain waves.
Researchers found that MDMA enhances the brain's response to emotional faces, particularly happy and angry ones, distinguishing its effects from methamphetamine and highlighting its unique impact on social and emotional processing.
Psilocybin, found in magic mushrooms, increases brain connectivity, leading to profound changes in perception and feelings of unity, helping explain mystical experiences and its potential for treating mental health disorders.
Psychedelic use is linked to better cognitive functioning and fewer depressive symptoms in middle-aged and older adults, according to a recent study.